| 1 |
Gu S, Qian S, Lin S, Ye D, Li Q, Yang J, Ying X, Li Z, Tang M, Wang J, Chen K, Jin M. Promoter hypermethylation of GALR1 acts as an early epigenetic susceptibility event in colorectal carcinogenesis. J Hum Genet 2022. [PMID: 35606503 DOI: 10.1038/s10038-022-01038-9] [Reference Citation Analysis]
|
| 2 |
Priya S, Kaur E, Kulshrestha S, Pandit A, Gross I, Kumar N, Agarwal H, Khan A, Shyam R, Bhagat P, Prabhu JS, Nagarajan P, Deo SVS, Bajaj A, Freund JN, Mukhopadhyay A, Sengupta S. CDX2 inducible microRNAs sustain colon cancer by targeting multiple DNA damage response pathway factors. J Cell Sci 2021;134:jcs258601. [PMID: 34369561 DOI: 10.1242/jcs.258601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 3 |
Ortiz-Barahona V, Joshi RS, Esteller M. Use of DNA methylation profiling in translational oncology. Semin Cancer Biol 2020:S1044-579X(20)30271-6. [PMID: 33352265 DOI: 10.1016/j.semcancer.2020.12.011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
|
| 4 |
Wilkinson NA, Mnuskin KS, Ashton NW, Woodgate R. Ubiquitin and Ubiquitin-Like Proteins Are Essential Regulators of DNA Damage Bypass. Cancers (Basel) 2020;12:E2848. [PMID: 33023096 DOI: 10.3390/cancers12102848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 5 |
Delmonico L, Silva Magalhães Costa MA, Gomes RJ, De Oliveira Vieira P, Da Silva ABP, Fournier MV, Scherrer LR, De Azevedo CM, Ornellas MHF, Alves G. Methylation profiling in promoter sequences of ATM and CDKN2A (p14ARF/p16INK4a ) genes in blood and cfDNA from women with impalpable breast lesions. Oncol Lett 2020;19:3003-10. [PMID: 32218857 DOI: 10.3892/ol.2020.11382] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 6 |
Jacenik D, Beswick EJ, Krajewska WM, Prossnitz ER. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis. World J Gastroenterol 2019; 25(30): 4092-4104 [PMID: 31435166 DOI: 10.3748/wjg.v25.i30.4092] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 32] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 7 |
Hirakawa T, Nasu K, Aoyagi Y, Takebayashi K, Zhu R, Narahara H. ATM expression is attenuated by promoter hypermethylation in human ovarian endometriotic stromal cells. Molecular Human Reproduction 2019;25:295-304. [DOI: 10.1093/molehr/gaz016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Randon G, Fucà G, Rossini D, Raimondi A, Pagani F, Perrone F, Tamborini E, Busico A, Peverelli G, Morano F, Niger M, Antista M, Corallo S, Saggio S, Borelli B, Zucchelli G, Milione M, Pruneri G, Di Bartolomeo M, Falcone A, de Braud F, Cremolini C, Pietrantonio F. Prognostic impact of ATM mutations in patients with metastatic colorectal cancer. Sci Rep 2019;9:2858. [PMID: 30814645 DOI: 10.1038/s41598-019-39525-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 9 |
Sriramulu S, Ramachandran M, Subramanian S, Kannan R, Gopinath M, Sollano J, Bissi L, Banerjee A, Marotta F, Pathak S. A review on role of ATM gene in hereditary transfer of colorectal cancer. Acta Biomed 2019;89:463-9. [PMID: 30657113 DOI: 10.23750/abm.v89i4.6095] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 10 |
Dhont L, Pintilie M, Kaufman E, Navab R, Tam S, Burny A, Shepherd F, Belayew A, Tsao MS, Mascaux C. Helicase-like transcription factor expression is associated with a poor prognosis in Non-Small-Cell Lung Cancer (NSCLC). BMC Cancer 2018;18:429. [PMID: 29661164 DOI: 10.1186/s12885-018-4215-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 11 |
Liang TJ, Wang HX, Zheng YY, Cao YQ, Wu X, Zhou X, Dong SX. APC hypermethylation for early diagnosis of colorectal cancer: a meta-analysis and literature review. Oncotarget. 2017;8:46468-46479. [PMID: 28515349 DOI: 10.18632/oncotarget.17576] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 12 |
Petersen LF, Klimowicz AC, Otsuka S, Elegbede AA, Petrillo SK, Williamson T, Williamson CT, Konno M, Lees-Miller SP, Hao D, Morris D, Magliocco AM, Bebb DG. Loss of tumour-specific ATM protein expression is an independent prognostic factor in early resected NSCLC. Oncotarget 2017;8:38326-36. [PMID: 28418844 DOI: 10.18632/oncotarget.16215] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 13 |
Cao X, Tang Q, Holland-Letz T, Gündert M, Cuk K, Schott S, Heil J, Golatta M, Sohn C, Schneeweiss A, Burwinkel B. Evaluation of Promoter Methylation of RASSF1A and ATM in Peripheral Blood of Breast Cancer Patients and Healthy Control Individuals. Int J Mol Sci 2018;19:E900. [PMID: 29562656 DOI: 10.3390/ijms19030900] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 14 |
Wang S, Zhang Y, Chen M, Wang Y, Feng Y, Xu Z, Zhang D, Sun Y, Fu Z. Association of genetic variants in ATR-CHEK1 and ATM-CHEK2 pathway genes with risk of colorectal cancer in a Chinese population. Oncotarget 2018;9:26616-24. [PMID: 29928473 DOI: 10.18632/oncotarget.24299] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 15 |
Barrow TM. Epigenetic Epidemiology for Cancer Risk. Epigenetic Mechanisms in Cancer 2018. [DOI: 10.1016/b978-0-12-809552-2.00008-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 16 |
Dillon MT, Harrington KJ. Targeting ATR for Cancer Therapy: ATR-Targeted Drug Candidates. Cancer Drug Discovery and Development 2018. [DOI: 10.1007/978-3-319-75836-7_5] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 17 |
Ayala-Calvillo E, Mojica-Vázquez LH, García-Carrancá A, González-Maya L. Wnt/β‑catenin pathway activation and silencing of the APC gene in HPV‑positive human cervical cancer‑derived cells. Mol Med Rep 2018;17:200-8. [PMID: 29115417 DOI: 10.3892/mmr.2017.7853] [Cited by in Crossref: 5] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 18 |
Bustos V, Nolan ÁM, Nijhuis A, Harvey H, Parker A, Poulsom R, McBryan J, Thomas W, Silver A, Harvey BJ. GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions. Oncotarget 2017;8:84258-75. [PMID: 29137421 DOI: 10.18632/oncotarget.20653] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 19 |
Liu J, Li H, Sun L, Wang Z, Xing C, Yuan Y. Aberrantly methylated-differentially expressed genes and pathways in colorectal cancer. Cancer Cell Int 2017;17:75. [PMID: 28794688 DOI: 10.1186/s12935-017-0444-4] [Cited by in Crossref: 48] [Cited by in F6Publishing: 53] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 20 |
Song L, Li Y. The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis. Stem Cell Rev and Rep 2016;12:573-83. [DOI: 10.1007/s12015-016-9672-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 21 |
Dhont L, Mascaux C, Belayew A. The helicase-like transcription factor (HLTF) in cancer: loss of function or oncomorphic conversion of a tumor suppressor? Cell Mol Life Sci 2016;73:129-47. [PMID: 26472339 DOI: 10.1007/s00018-015-2060-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 22 |
Zhou Z, Zhang H, Lai J, Diao D, Li W, Dang C, Song Y. Relationships between p14ARF Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis. PLoS One 2016;11:e0152050. [PMID: 26999279 DOI: 10.1371/journal.pone.0152050] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 23 |
Feng X, Li H, Dean M, Wilson HE, Kornaga E, Enwere EK, Tang P, Paterson A, Lees-Miller SP, Magliocco AM, Bebb G. Low ATM protein expression in malignant tumor as well as cancer-associated stroma are independent prognostic factors in a retrospective study of early-stage hormone-negative breast cancer. Breast Cancer Res 2015;17:65. [PMID: 25935535 DOI: 10.1186/s13058-015-0575-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 24 |
Yan ZH, Cui LH, Wang XH, Li C, He X. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer. World J Gastroenterol 2014; 20(48): 18338-18345 [PMID: 25561800 DOI: 10.3748/wjg.v20.i48.18338] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 25 |
Arcolia V, Paci P, Dhont L, Chantrain G, Sirtaine N, Decaestecker C, Remmelink M, Belayew A, Saussez S. Helicase-like transcription factor: a new marker of well-differentiated thyroid cancers. BMC Cancer 2014;14:492. [PMID: 25005870 DOI: 10.1186/1471-2407-14-492] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 26 |
Naselli F, Tesoriere L, Caradonna F, Bellavia D, Attanzio A, Gentile C, Livrea MA. Anti-proliferative and pro-apoptotic activity of whole extract and isolated indicaxanthin from Opuntia ficus-indica associated with re-activation of the onco-suppressor p16(INK4a) gene in human colorectal carcinoma (Caco-2) cells. Biochem Biophys Res Commun 2014;450:652-8. [PMID: 24937448 DOI: 10.1016/j.bbrc.2014.06.029] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 27 |
Philipp AB, Nagel D, Stieber P, Lamerz R, Thalhammer I, Herbst A, Kolligs FT. Circulating cell-free methylated DNA and lactate dehydrogenase release in colorectal cancer. BMC Cancer 2014;14:245. [PMID: 24708595 DOI: 10.1186/1471-2407-14-245] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 28 |
Molinari C, Casadio V, Foca F, Zingaretti C, Giannini M, Avanzolini A, Lucci E, Saragoni L, Passardi A, Amadori D. Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy? J Cell Physiol. 2013;228:2343-2349. [PMID: 23702823 DOI: 10.1002/jcp.24405] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 29 |
Veuger S, Curtin NJ. Inhibition of DNA Repair as a Therapeutic Target. Cancer Drug Design and Discovery 2014. [DOI: 10.1016/b978-0-12-396521-9.00008-5] [Reference Citation Analysis]
|
| 30 |
Zeng JR, Ruan ZM, Mo LF, Chen H. Relationship between MLH1 promoter methylation and colorectal cancer: A meta-analysis. Shijie Huaren Xiaohua Zazhi 2013; 21(36): 4204-4209 [DOI: 10.11569/wcjd.v21.i36.4204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 31 |
Rivenbark AG, Coleman WB. Epigenetic Biomarkers in Cancer Detection and Diagnosis. Toxicology and Epigenetics 2012. [DOI: 10.1002/9781118349045.ch16] [Reference Citation Analysis]
|
| 32 |
Sandhu S, Wu X, Nabi Z, Rastegar M, Kung S, Mai S, Ding H. Loss of HLTF function promotes intestinal carcinogenesis. Mol Cancer 2012;11:18. [PMID: 22452792 DOI: 10.1186/1476-4598-11-18] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 33 |
Kycler W, Szarzyńska B, Loziński C, Korski K, Lamperska K. Analysis of O6-methylguanine-DNA methyltransferase methylation status in sporadic colon polyps. Rep Pract Oncol Radiother 2012;17:13-8. [PMID: 24376999 DOI: 10.1016/j.rpor.2011.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 34 |
Weinfeld M, Lees-miller SP. DNA Double-Strand Break Repair by Non-homologous End Joining and Its Clinical Relevance. DNA Repair in Cancer Therapy 2012. [DOI: 10.1016/b978-0-12-384999-1.10008-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 35 |
Lee KH, Lee JS, Nam JH, Choi C, Lee MC, Park CS, Juhng SW, Lee JH. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Langenbecks Arch Surg. 2011;396:1017-1026. [PMID: 21706233 DOI: 10.1007/s00423-011-0812-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 36 |
Conerly M, Grady WM. Insights into the role of DNA methylation in disease through the use of mouse models. Dis Model Mech. 2010;3:290-297. [PMID: 20427558 DOI: 10.1242/dmm.004812] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 37 |
Spisák S, Kalmár A, Galamb O, Sipos F, Wichmann B, Molnár B, Tulassay Z. [Identification of methylation related genes from laser capture microdissected colon samples during investigation of adenoma-carcinoma sequence]. Orv Hetil 2010;151:805-14. [PMID: 20442051 DOI: 10.1556/OH.2010.28867] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 38 |
Borinstein SC, Conerly M, Dzieciatkowski S, Biswas S, Washington MK, Trobridge P, Henikoff S, Grady WM. Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model. Mol Carcinog 2010;49:94-103. [PMID: 19777566 DOI: 10.1002/mc.20581] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 39 |
Berginc G, Bracko M, Glavac D. MS-MLPA reveals progressive age-dependent promoter methylation of tumor suppressor genes and possible role of IGSF4 gene in colorectal carcinogenesis of microsatellite instable tumors. Cancer Invest 2010;28:94-102. [PMID: 19995226 DOI: 10.3109/07357900902849673] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 40 |
Carvajal-carmona LG, Silver A, Tomlinson IP. Molecular Genetics of Familial Adenomatous Polyposis. Hereditary Colorectal Cancer 2010. [DOI: 10.1007/978-1-4419-6603-2_3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 41 |
Howard JH, Frolov A, Tzeng CW, Stewart A, Midzak A, Majmundar A, Godwin A, Heslin M, Bellacosa A, Arnoletti JP. Epigenetic downregulation of the DNA repair gene MED1/MBD4 in colorectal and ovarian cancer. Cancer Biol Ther. 2009;8:94-100. [PMID: 19127118 DOI: 10.4161/cbt.8.1.7469] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 42 |
Rivenbark AG, Coleman WB. The Role of Mutation and Epimutation in the Development of Human Disease. Molecular Pathology Library 2009. [DOI: 10.1007/978-0-387-89626-7_5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 43 |
Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer. 2008;7:94. [PMID: 19117505 DOI: 10.1186/1476-4598-7-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 44 |
Ahlquist T, Lind GE, Costa VL, Meling GI, Vatn M, Hoff GS, Rognum TO, Skotheim RI, Thiis-Evensen E, Lothe RA. Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers. Mol Cancer. 2008;7:94. [PMID: 19117505 DOI: 10.1186/1476-4598-7-94] [Cited by in Crossref: 92] [Cited by in F6Publishing: 94] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 45 |
Segditsas S, Sieber OM, Rowan A, Setien F, Neale K, Phillips RK, Ward R, Esteller M, Tomlinson IP. Promoter hypermethylation leads to decreased APC mRNA expression in familial polyposis and sporadic colorectal tumours, but does not substitute for truncating mutations. Exp Mol Pathol. 2008;85:201-206. [PMID: 18977219 DOI: 10.1016/j.yexmp.2008.09.006] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 46 |
Müller A, Zielinski D, Friedrichs N, Oberschmid B, Merkelbach-Bruse S, Schackert HK, Linnebacher M, von Knebel Doeberitz M, Büttner R, Rüschoff J; German HNPCC Consortium, German Cancer Aid Deutsche Krebshilfe. Reduced mRNA expression in paraffin-embedded tissue identifies MLH1- and MSH2-deficient colorectal tumours and potential mutation carriers. Virchows Arch 2008;453:9-16. [PMID: 18581137 DOI: 10.1007/s00428-008-0637-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 47 |
Rojas A, Meherem S, Kim YH, Washington MK, Willis JE, Markowitz SD, Grady WM. The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer. Int J Cancer 2008;123:14-21. [PMID: 18425817 DOI: 10.1002/ijc.23608] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 48 |
Berkhout M, Nagtegaal ID, Cornelissen SJ, Dekkers MM, van de Molengraft FJ, Peters WH, Nagengast FM, van Krieken JH, Jeuken JW. Chromosomal and methylation alterations in sporadic and familial adenomatous polyposis-related duodenal carcinomas. Mod Pathol 2007;20:1253-62. [PMID: 17873900 DOI: 10.1038/modpathol.3800952] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 49 |
Bose S, Starczynski J, Chukwuma M, Baumforth K, Wei W, Morgan S, Byrd P, Ying J, Grundy R, Mann J, Tao Q, Taylor A, Murray P, Stankovic T. Down-regulation of ATM protein in HRS cells of nodular sclerosis Hodgkin's lymphoma in children occurs in the absence of ATM gene inactivation. J Pathol 2007;213:329-36. [DOI: 10.1002/path.2232] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 50 |
Rivenbark AG, Coleman WB. Practical applications for epigenetic biomarkers in cancer diagnostics. Expert Opin Med Diagn 2007;1:17-30. [PMID: 23489266 DOI: 10.1517/17530059.1.1.17] [Reference Citation Analysis]
|
| 51 |
Kwong LN, Weiss KR, Haigis KM, Dove WF. Atm is a negative regulator of intestinal neoplasia. Oncogene 2008;27:1013-8. [PMID: 17700532 DOI: 10.1038/sj.onc.1210708] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 52 |
Leung WK, To KF, Man EP, Chan MW, Hui AJ, Ng SS, Lau JY, Sung JJ. Detection of hypermethylated DNA or cyclooxygenase-2 messenger RNA in fecal samples of patients with colorectal cancer or polyps. Am J Gastroenterol 2007;102:1070-6. [PMID: 17378912 DOI: 10.1111/j.1572-0241.2007.01108.x] [Cited by in Crossref: 72] [Cited by in F6Publishing: 84] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 53 |
Hazra A, Wu K, Kraft P, Fuchs CS, Giovannucci EL, Hunter DJ. Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. Carcinogenesis 2007;28:1510-9. [PMID: 17389618 DOI: 10.1093/carcin/bgm062] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 54 |
Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007;56:140-8. [PMID: 16840508 DOI: 10.1136/gut.2005.088799] [Cited by in Crossref: 125] [Cited by in F6Publishing: 136] [Article Influence: 7.8] [Reference Citation Analysis]
|
| 55 |
Kann L, Han J, Ahlquist D, Levin T, Rex D, Whitney D, Markowitz S, Shuber A. Improved Marker Combination for Detection of De Novo Genetic Variation and Aberrant DNA in Colorectal Neoplasia. Clinical Chemistry 2006;52:2299-302. [DOI: 10.1373/clinchem.2007.070896] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 56 |
Lu Q, Qiu X, Hu N, Wen H, Su Y, Richardson BC. Epigenetics, disease, and therapeutic interventions. Ageing Res Rev 2006;5:449-67. [PMID: 16965942 DOI: 10.1016/j.arr.2006.07.001] [Cited by in Crossref: 74] [Cited by in F6Publishing: 67] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 57 |
Kim YH, Petko Z, Dzieciatkowski S, Lin L, Ghiassi M, Stain S, Chapman WC, Washington MK, Willis J, Markowitz SD, Grady WM. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer. Genes Chromosomes Cancer 2006;45:781-9. [PMID: 16708352 DOI: 10.1002/gcc.20341] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 4.9] [Reference Citation Analysis]
|
| 58 |
Davey GM, Heath WR, Starr R. SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation. Tissue Antigens 2006;67:1-9. [PMID: 16451196 DOI: 10.1111/j.1399-0039.2005.00532.x] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 59 |
Grady WM. Epigenetic events in the colorectum and in colon cancer. Biochem Soc Trans 2005;33:684-8. [PMID: 16042574 DOI: 10.1042/BST0330684] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 60 |
Leung WK, To KF, Man EP, Chan MW, Bai AH, Hui AJ, Chan FK, Sung JJ. Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer. Am J Gastroenterol 2005;100:2274-9. [PMID: 16181380 DOI: 10.1111/j.1572-0241.2005.50412.x] [Cited by in Crossref: 101] [Cited by in F6Publishing: 114] [Article Influence: 5.6] [Reference Citation Analysis]
|
| 61 |
Yoshimura A, Nishinakamura H, Matsumura Y, Hanada T. Negative regulation of cytokine signaling and immune responses by SOCS proteins. Arthritis Res Ther 2005;7:100-10. [PMID: 15899058 DOI: 10.1186/ar1741] [Cited by in Crossref: 124] [Cited by in F6Publishing: 124] [Article Influence: 6.9] [Reference Citation Analysis]
|
